Cargando…
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is a major subtype of lung cancer, the prognosis of patients with which is associated with both lncRNAs and cancer immunity. In this study, we collected gene expression data of 585 LUAD patients from The Cancer Genome Atlas (TCGA) database and 605 subjects from the Gene Ex...
Autores principales: | Wang, Jixin, Yin, Xiangjun, Zhang, Yin-Qiang, Ji, Xuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940686/ https://www.ncbi.nlm.nih.gov/pubmed/33708243 http://dx.doi.org/10.3389/fgene.2021.639254 |
Ejemplares similares
-
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021) -
Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022) -
Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021) -
Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022) -
Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma
por: Zhang, Chuanhao, et al.
Publicado: (2022)